Document:

Forbearance Agreement

 Exhibit 10.1 
 FORBEARANCE AGREEMENT 
 This FORBEARANCE AGREEMENT (this
“Agreement”), dated as of June 30, 2011, is by and among HILL INTERNATIONAL, INC., a Delaware corporation (the “Borrower”), the undersigned Lenders (as defined below) and BANK OF AMERICA, N.A., as
Administrative Agent (the “Administrative Agent”) for the Secured Parties (as defined in the Credit Agreement defined below). 
 RECITALS: 
 A. The Borrower is party to that certain Credit Agreement,
dated as of June 30, 2009 (as otherwise amended, restated or modified from time to time, the “Credit Agreement”), among the Borrower, each lender from time to time party thereto (collectively, the “Lenders” and
each a “Lender”), and the Administrative Agent. Capitalized terms used herein but not otherwise defined herein shall have the meanings given such terms in the Credit Agreement. 

B. The Events of Default described on Exhibit A hereto (collectively, the “Specified Defaults”) have occurred and
are continuing and the Borrower has requested that the Agent and the Required Lenders forbear from enforcing remedies with respect to the Specified Defaults in accordance with the terms and conditions of this Agreement. 

NOW, THEREFORE, in consideration of the premises and the mutual covenants hereinafter contained, the parties hereto agree as
follows: 
 Section 1. FORBEARANCE. The Administrative Agent and the Secured Parties hereby agree to forbear from
enforcing their remedies against the Borrower with respect to the Specified Defaults during the period from the date hereof through the earlier of (a) the date of the occurrence of any Default or Event of Default other than the Specified
Defaults and (b) September 30, 2011 (the “Forbearance Period”). Upon the occurrence of any Default or Event of Default (other than the Specified Defaults), the foregoing agreement to forbear from the exercise of remedies
with respect to the Specified Defaults shall automatically terminate without any notice or other action by the Administrative Agent or the Secured Parties, any cure period set forth under Section 8.01 of the Credit Agreement shall be
deemed to have lapsed, and the Administrative Agent and the Secured Parties may immediately enforce any and all of their rights under the Credit Agreement and the other Loan Documents. The agreement of the Administrative Agent and Secured Parties
set forth in this Section 1 is not intended as, nor shall such forbearance or any failure by the Administrative Agent or any Secured Party to enforce any of its rights or remedies with respect to any Default or Event of Default
(including, without limitation, the Specified Defaults) on or prior to the Effective Date (as defined below) hereof be deemed to constitute, a waiver of any of the Specified Defaults or of any other Default or Event of Default that now exists or
arises after the date hereof or of any of the Administrative Agent’s or any Secured Party’s rights and remedies with respect thereto. 
 Section 2. PRICING AND AVAILABILITY. In consideration of the agreement of the Agent and the Secured Parties to forbear from the enforcement of remedies in accordance with Section 1
hereof, the undersigned parties hereby acknowledge and agree, notwithstanding anything herein or in any other Loan Document to the contrary, as follows: 
 (a) during the Forbearance Period, the Applicable Rate shall be determined based on Pricing Level 4 plus, in all cases, 0.50%; and 

 (b) during the Forbearance Period (subject to any amendment to the Credit
Agreement after the date hereof), (i) the Outstanding Amount of all Loans shall not exceed $80,000,000 (after giving effect to any Revolving Borrowing) and (ii) the only Letters of Credit that shall be permitted are (x) such Letters
of Credit issued and outstanding as of June 28, 2011, (y) such Letters of Credit requested after June 28, 2011 that meet the requirements set forth in Schedule 2(a), and (z) any other such Letters of Credit with the
consent of the Required Lenders. 
 Section 3. COVENANTS. In consideration of the agreement of the Administrative
Agent and the Secured Parties to forbear from the enforcement of remedies in accordance with Section 1 hereof, the Borrower hereby covenants and agrees as follows: 

(a) The Borrower shall (i) cooperate fully with the Administrative Agent in engaging a consultant (the
“Consultant”) for the purposes of (x) analyzing the reasonableness of the 2011 and 2012 projections delivered to the Administrative Agent, (y) evaluating the Borrower’s short-term liquidity position and usage
requirements for the revolving credit facility under the Credit Agreement, and (z) responding to other requests of the Lenders, and (ii) reimburse the Administrative Agent for all reasonable out-of-pocket expenses related thereto as
required by Section 10.04 of the Credit Agreement. 
 (b) Neither the Borrower nor any Subsidiary
shall, during the Forbearance Period, enter into any agreement, contract, binding commitment or other arrangement providing for any purchase or other acquisition that would otherwise be permitted by Section 7.03(f) of the Credit
Agreement, or take any action to solicit the tender of securities or proxies in respect thereof in order to effect any such purchase or other acquisition, without the consent of the Required Lenders. 

(c) Neither the Borrower nor any Subsidiary shall, during the Forbearance Period, make any Restricted Payment that would
otherwise permitted by Section 7.06 of the Credit Agreement or agree to make any Restricted Payment, without the consent of the Required Lenders. 
 (d) During the Forbearance Period, the Borrower shall not be permitted to request any Eurodollar Rate Loan; each Eurodollar Rate Loan outstanding on the date hereof shall, at the end of the Interest
Period applicable thereto, either be repaid in full or converted to a Base Rate Loan. 
 Section 4. ACKNOWLEDGMENT OF
OBLIGATIONS. The Borrower hereby acknowledges that it is indebted to the Secured Parties for repayment of the outstanding Obligations under the Credit Agreement, the Notes, the other Loan Documents, including, without limitation, the amounts set
forth on Schedule 4 hereto as of June 30, 2011, and for any additional accrued interest, costs, indemnification obligations and attorneys’ fees and expenses, as provided in the Loan Documents. 

Section 5. CONDITIONS PRECEDENT. The parties hereto agree that the forbearance set forth in Section 1 above shall
not be effective until the satisfaction of each of the following conditions precedent (the date on which all such conditions have been satisfied, the “Effective Date”): 

(a) Documentation. The Administrative Agent shall have received (i) a counterpart of this Agreement, duly executed and
delivered by the Borrower and Lenders constituting the Required Lenders and (ii) such other documents and certificates as the Administrative Agent or its counsel may reasonably request relating to the organization, existence and good standing
of the Borrower, the authorization of this Agreement and any other legal matters relating to the Borrower or the transactions contemplated hereby. 

  
 2 

 (b) Work Fee. The Borrower shall have paid to each Lender that signs this Agreement
on or before the Effective Date a fee in an amount equal to 0.25% times such Lender’s Commitment, which fee shall be fully earned and due on the Effective Date shall be nonrefundable. 

(c) Fees and Expenses. All fees and expenses of counsel to the Administrative Agent estimated to date shall have been paid in full
(without prejudice to final settling of accounts for such fees and expenses). 
 Section 6. RELEASE. The Borrower
hereby acknowledges and agrees that: (a) each of the Administrative Agent, each other Secured Party and each of their respective affiliates, employees, officers, agents, contractors and attorneys-in-fact (collectively, the “Lender
Parties”) have acted in good faith in negotiating and entering into this Agreement and that the provisions hereof are not in breach or violation of any duty or obligation, express or implied, of such Lender Party to the Borrower;
(b) each of the Lender Parties have fully performed all of their express and implied obligations to the Borrower in connection with the Loan Documents and with respect to all other loan and contractual relationships between the Administrative
Agent and the Secured Parties, on the one hand, and the Borrower, on the other hand; and (c) the Borrower has no existing defense, counterclaim, offset, cross-complaint, claim, demand or cause of action against any of the Lender Parties of any
nature, whether in tort or in contract related to the Loan Documents. In consideration for the execution of this Agreement, the Borrower does hereby release and forever discharge all of the Lender Parties from any and all actions, causes of action,
debts, dues, claims, demands, liabilities and obligations of every kind and nature, both in law and in equity, known or unknown, now existing, which might be asserted against any Lender Party arising out of, based upon, or associated with any action
taken or not taken by any Lender Party from the beginning of time to the date of this Agreement. The provisions of this Section 6 shall survive the termination of this Agreement and repayment and performance in full of the Obligations
under the Loan Documents. 
 Section 6. REINSTATEMENT. If any consideration transferred to any Lender Party
hereunder shall be avoided in whole or in part or otherwise forfeited or refunded to a receiver, trustee, bankruptcy estate or otherwise, or any Lender Party is required to pay any claim arising out of the Loan Documents or any transaction related
thereto, or any Lender Party agrees to pay any such amount as part of a compromise or settlement of pending or threatened claims, then the Obligations due under the Loan Documents shall be reinstated to the extent of such repayment and the Borrower
shall pay over to such Lender Party all such amounts. 
 Section 7. CROSS-REFERENCES. References in this Agreement
to any Section are, unless otherwise specified, to such Section of this Agreement. 
 Section 8. INSTRUMENT PURSUANT TO
CREDIT AGREEMENT; FURTHER ASSURANCES. This Agreement is a Loan Document executed pursuant to the Credit Agreement and shall (unless otherwise expressly indicated herein) be construed, administered and applied in accordance with the terms and
provisions of the Credit Agreement. Section 6.12 of the Credit Agreement is incorporated herein by reference and the Borrower acknowledges and agrees to comply therewith, including, without limitation, taking all such acts and entering
into such instruments with respect to the Loan Documents or otherwise as the Administrative Agent, or any Lender through the Administrative Agent, may reasonably require. 
 Section 9. MISCELLANEOUS. 
 (a) Ratification and Confirmation of
Loan Documents. The Borrower hereby consents, acknowledges and agrees to the waivers and consents set forth herein and hereby confirms and ratifies in all respects the Loan Documents to which it is a party (including without limitation, the
continuation and extension of the liens granted under the Collateral Documents to secure the Obligations). 

  
 3 

 (b) Fees and Expenses. Without limiting the provisions of Section 10.04
of the Credit Agreement, the Borrower shall pay on demand all reasonable costs and expenses of the Administrative Agent in connection with the preparation, reproduction, execution, and delivery of this Agreement and any other documents prepared in
connection herewith, including, without limitation, the reasonable fees and out-of-pocket expenses of counsel for the Administrative Agent. 
 (c) Headings. Section and subsection headings in this Agreement are included herein for convenience of reference only and shall not constitute a part of this Agreement for any other purpose or be
given any substantive effect. 
 (d) Governing Law; Waiver of Jury Trial. This Agreement shall be governed by and
construed in accordance with the laws of the State of New York, and shall be further subject to the provisions of Sections 10.15 and 10.16 of the Credit Agreement. 

(e) Counterparts. This Agreement may be executed in any number of counterparts, each of which when executed and delivered shall be
deemed to be an original, and all of which when taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page of this Agreement by facsimile or electronic transmission (including .pdf file) shall
be effective as delivery of a manually executed counterpart hereof. 
 (f) Entire Agreement. This Agreement, together
with all the Loan Documents (collectively, the “Relevant Documents”), sets forth the entire understanding and agreement of the parties hereto in relation to the subject matter hereof and supersedes any prior negotiations and
agreements among the parties relating to such subject matter. No promise, condition, representation or warranty, express or implied, not set forth in the Relevant Documents shall bind any party hereto, and no such party has relied on any such
promise, condition, representation or warranty. Each of the parties hereto acknowledges that, except as otherwise expressly stated in the Relevant Documents, no representations, warranties or commitments, express or implied, have been made by any
party to the other. None of the terms or conditions of this Agreement may be changed, modified, waived or canceled orally or otherwise except in a writing signed by the Administrative Agent for such purpose. 

(g) Enforceability. Should any one or more of the provisions of this Agreement be determined to be illegal or unenforceable as to
one or more of the parties hereto, all other provisions nevertheless shall remain effective and binding on the parties hereto. 

(h) Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the Borrower, the Administrative
Agent, each Lender and their respective successors and assigns (subject to Section 10.06 of the Credit Agreement); provided that the Borrower may not assign or transfer any of its interest hereunder without the prior written
consent of the Agent. 
 (i) Loan Documents. Except as expressly set forth herein, the waivers and consents provided
herein shall not by implication or otherwise limit, constitute a waiver of, or otherwise affect the rights and remedies of the Agent and the Lenders under the Credit Agreement or any other Loan Document, nor shall they constitute a waiver of any
Event of Default, nor shall they alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any other Loan Document. The forbearance and other agreements
described herein shall apply and be effective only with respect to the Specified Defaults specifically referred to in the applicable provisions hereof. The Credit Agreement and the other Loan Documents shall continue in full

  
 4 

 
force and effect in accordance with the provisions thereof. As used in the Credit Agreement, the terms “Agreement”, “herein”, “hereinafter”, “hereunder”,
“hereto” and words of similar import shall mean, from and after the date hereof, the Credit Agreement as amended hereby. 
 [Remainder of Page Intentionally Left Blank; Signature Pages Follow] 

  
 5 

 IN WITNESS WHEREOF, each of the parties hereto has caused a counterpart of this
Agreement to be duly executed and delivered as of the date first above written. 
  

			
	BORROWER:
	
	HILL INTERNATIONAL, INC.
		
	By:	 	 /s/ Irvin E. Richter

	Name:	 	 Irvin E. Richter

	Title:	 	 Chairman and Chief Executive Officer

  
 Forbearance
Agreement 
 Signature Page 

 
			
	ADMINISTRATIVE AGENT:
	
	BANK OF AMERICA, N.A., as
	Administrative Agent
		
	By:	 	 /s/ Rosanne Parsill

	Name:	 	 Rosanne Parsill

	Title:	 	 Vice President

  
 Forbearance
Agreement 
 Signature Page 

 
			
	LENDERS:
	
	BANK OF AMERICA, N.A., as
	Lender, Swing Line Lender and L/C Issuer
		
	By:	 	 /s/ George Linhart

	Name:	 	 George Linhart

	Title:	 	 Senior Vice President

  
 Forbearance
Agreement 
 Signature Page 

 
			
	CAPITAL ONE, N.A., as Lender
		
	By:	 	 /s/ Allison Sardo

	Name:	 	 Allison Sardo

	Title:	 	 Senior Vice President

  
 Forbearance
Agreement 
 Signature Page 

 
			
	THE PRIVATEBANK AND TRUST COMPANY, as Lender
		
	By:	 	 /s/ Matthew Gibbons

	Name:	 	 Matthew Gibbons

	Title:	 	 Managing Director

  
 Forbearance
Agreement 
 Signature Page 

 
			
	PNC BANK NATIONAL ASSOCIATION, as Lender
		
	By:	 	 /s/ William Cornelius

	Name:	 	 William Cornelius

	Title:	 	 Vice President

  
 Forbearance
Agreement 
 Signature Page 

 EXHIBIT A 
 Specified Default 
 Sections 7.11(b), 7.11(c) and 8.01(b) of
the Credit Agreement – failure of the Borrower to comply with the Consolidated Leverage Ratio and Consolidated Fixed Charge Coverage Ratio during the Forbearance Period. 
 Exhibit A 

 SCHEDULE 2(a) 
 to Forbearance Agreement 
 Approved Letters of Credit

  

							
	 Beneficiary
	  	Maximum Amount	 	  	 Purpose

	 Ministry of Infrastructure, Kosovo
	  	$	2,000,000	  	  	Performance Bond and Advance Payment Guarantee
	 Aqua Braila SV, Romania
	  	$	600,000	  	  	Advance payment guarantee
	 Aqua Salaz SV, Romania
	  	$	70,000	  	  	Advance payment guarantee
	 Aqua Timisoara SV, Romania
	  	$	700,000	  	  	Performance Bond and Advance Payment Guarantee
	 Aba Canal SA, Sibiu, Romania
	  	$	600,000	  	  	Performance Bond and Advance Payment Guarantee
	 Jeddah Municipality, Saudi Arabia
	  	$	225,000	  	  	Bid Bond
	 HSBC(china) BUCG Sanas Airport
	  	$	2,000,000	  	  	Advance payment guarantee
	 HSS Holdings - Comoros Island Development Program
	  	$	12,000,000	  	  	Advance payment guarantee

 Schedule 2(a) to Forbearance Agreement 

 SCHEDULE 4 
 to Forbearance Agreement 
 Certain Outstanding Obligations as of
June 30, 2011 
  

					
	 Revolving Loans
	  			
	 Principal Amount of Outstanding Swing Line Loans:
	  	$	0.00	  
	 Accrued and unpaid interest on Swing Line Loans:
	  	$	0.00	  
	 Accrued and unpaid default interest:
	  	$	0.00	  
		
	 Letters of Credit Outstanding
	  			
	 Face Amount:
	  	$	11,643,500.35	  
	 Undrawn Amount:
	  	$	11,643,500.35	  
	 Expiration Date:
	  	 	multiple	  
	 Beneficiary:
	  	 	multiple	  
		
	 Accrued and unpaid Letter of Credit Fees:
	  	 	see invoice as of 6/30/11	  
	 Accrued and unpaid L/C Issuer fronting fees:
	  	 	N/A	  
		
	 Principal amount of Revolving Loans Outstanding:
	  	$	72,300,000.00	  
	 Accrued and unpaid interest on outstanding Revolving Loans:
	  	$	798,181.40	  
	 Accrued and unpaid default interest:
	  	$	0.00	  
		
	 Unused fees
	  	$	20,954.25	  

 Schedule 4 to Forbearance AgreementSECURITIES PURCHASE AGREEMENT

 EXHIBIT 10.1 
 SECURITIES PURCHASE AGREEMENT 
 This Securities Purchase Agreement (this
“Agreement”) is dated as of June 16, 2011, between SCOLR Pharma, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and
assigns, a “Purchaser” and collectively, the “Purchasers”). 
 WHEREAS, subject to the terms
and conditions set forth in this Agreement and pursuant to Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each
Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. 
 NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company
and each Purchaser agree as follows: 
 ARTICLE I. 
 DEFINITIONS 
 1.1 Definitions. In addition to the terms defined
elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given to such terms in the Debentures (as defined herein), and (b) the following terms have the meanings set forth in this
Section 1.1: 
 “Acquiring Person” shall have the meaning ascribed to such term in
Section 4.7. 
 “Action” shall have the meaning ascribed to such term in
Section 3.1(i). 
 “Affiliate” means any Person that, directly or indirectly through one or
more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act. 

“Board of Directors” means the board of directors of the Company. 

“Business Day” means any day except any Saturday, any Sunday, any day which is a federal legal holiday in
the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close. 
 “Closing” means the closing of the purchase and sale of the Securities pursuant to Section 2.1. 

“Closing Date” means the first Trading Day on which all of the Transaction Documents have been executed
and delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Subscription Amount 

 
and (ii) the Company’s obligations to deliver the Securities, in each case, have been satisfied or waived, but in no event later than the third Trading Day following the date hereof.

 “Commission” means the United States Securities and Exchange Commission. 

“Common Stock” means the common stock of the Company, par value $0.001 per share, and any other class of
securities into which such securities may hereafter be reclassified or changed. 
 “Common Stock
Equivalents” means any securities of the Company or the Subsidiaries which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other
instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock. 
 “Company Counsel” means Garvey Schubert Barer, with offices located at 1191 Second Ave, Suite 1800, Seattle, Washington 98101-2939. 

“Conversion Price” shall have the meaning ascribed to such term in the Debentures. 

“Debentures” means the 8% Senior Secured Convertible Debentures due, subject to the terms therein, two
years from their date of issuance, issued by the Company to the Purchasers hereunder, in the form of Exhibit A attached hereto. 
 “Disclosure Schedules” shall have the meaning ascribed to such term in Section 3.1. 
 “Effective Date” means the earliest of the date that (a) the Common Stock has been registered with the Commission pursuant to a registration statement, (b) all of the Securities
have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions or
(c) following the one year anniversary of the Closing Date provided that a holder of Securities is not an Affiliate of the Company, all of the Securities may be sold pursuant to an exemption from registration under Section 4(1) of the
Securities Act without volume or manner-of-sale restrictions and Company counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders of the Securities pursuant to such exemption which
opinion shall be in form and substance reasonably acceptable to such holders. 
 “Escrow Agent”
means Signature Bank, a New York State chartered bank, with offices at 261 Madison Avenue, New York, New York 10016. 
 “Escrow Agreement” means the escrow agreement entered into prior to the date hereof, by and among the Company, the Escrow Agent and Taglich Brothers Inc.

  
 2 

 
pursuant to which certain Purchasers, as instructed by the Company and Taglich Brothers Inc., shall deposit Subscription Amounts with the Escrow Agent to be applied to the transactions
contemplated hereunder. 
 “Evaluation Date” shall have the meaning ascribed to such term in
Section 3.1(q). 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended,
and the rules and regulations promulgated thereunder. 
 “Exempt Issuance” means the issuance of
(a) shares of Common Stock or options to employees, officers, directors, consultants and advisors of the Company pursuant to any stock or option plan duly adopted for such purpose, by a majority of the non-employee members of the Board of
Directors or a majority of the members of a committee of non-employee directors established for such purpose, (b) securities upon the conversion of any Securities issued hereunder and/or other securities exercisable or exchangeable for or
convertible into shares of Common Stock issued and outstanding on the date of this Agreement, provided that such securities have not been amended since the date of this Agreement to increase the number of such securities or to decrease the exercise
price, exchange price or conversion price of such securities other than as required by the terms thereof as in effect on the date hereof, (c) securities issued pursuant to acquisitions or strategic transactions approved by a majority of the
disinterested directors of the Company, provided that any such issuance shall only be to a Person (or to the equityholders of a Person) which is, itself or through its subsidiaries, an operating company or an owner of an asset in a business
synergistic with the business of the Company and shall provide to the Company additional benefits in addition to the investment of funds, but shall not include a transaction in which the Company is issuing securities primarily for the purpose of
raising capital or to an entity whose primary business is investing in securities; and (d) with the prior written consent of Taglich Brothers, Inc., up to an amount of Debentures equal to the difference between $1,750,000 and the aggregate
Subscription Amounts hereunder, on the same terms and conditions and prices as hereunder, with investors executing definitive agreements for the purchase of such securities and such transactions having closed on or before the Termination Date.

 “FCPA” means the Foreign Corrupt Practices Act of 1977, as amended. 

“FDA” shall have the meaning ascribed to such term in Section 3.1(jj). 

“FDCA” shall have the meaning ascribed to such term in Section 3.1(jj). 

“GAAP” shall have the meaning ascribed to such term in Section 3.1(g). 

“Indebtedness” shall have the meaning ascribed to such term in Section 3.1(z). 

“Intellectual Property Rights” shall have the meaning ascribed to such term in Section 3.1(n).

  
 3 

 “Legend Removal Date” shall have the meaning ascribed to
such term in Section 4.1(c). 
 “Liens” means a lien, charge, pledge, security interest,
encumbrance, right of first refusal, preemptive right or other restriction. 
 “Material Adverse
Effect” shall have the meaning assigned to such term in Section 3.1(a). 
 “Material
Permits” shall have the meaning ascribed to such term in Section 3.1(l). 
 “Maximum
Rate” shall have the meaning ascribed to such term in Section 5.17. 
 “Participation
Maximum” shall have the meaning ascribed to such term in Section 4.12(a). 

“Person” means an individual or corporation, partnership, trust, incorporated or unincorporated
association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 
 “Pharmaceutical Product” shall have the meaning ascribed to such term in Section 3.1(jj). 
 “Pre-Notice” shall have the meaning ascribed to such term in Section 4.12(b). 
 “Pro Rata Portion” shall have the meaning ascribed to such term in Section 4.12(e). 
 “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether
commenced or threatened. 
 “Public Information Failure” shall have the meaning ascribed to such
term in Section 4.3(b). 
 “Public Information Failure Payments” shall have the meaning
ascribed to such term in Section 4.3(b). 
 “Purchaser Party” shall have the meaning
ascribed to such term in Section 4.10. 
 “Required Approvals” shall have the meaning
ascribed to such term in Section 3.1(d). 
 “Required Minimum” means, as of any date, the
maximum aggregate number of shares of Common Stock then issued or potentially issuable in the future pursuant to the Transaction Documents, including any Underlying Shares issuable upon conversion in full of all Debentures, ignoring any conversion
limits set forth therein, and assuming that 

  
 4 

 
the Conversion Price is at all times on and after the date of determination 75% of the then Conversion Price on the Trading Day immediately prior to the date of determination. 

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may
be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 
 “SEC Reports” shall have the meaning ascribed to such term in Section 3.1(g). 
 “Securities” means the Debentures and the Underlying Shares. 
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations promulgated thereunder. 

“Security Agreement” means the Security Agreement, dated the date hereof, among the Company and the
Purchasers, in the form of Exhibit B attached hereto. 
 “Security Documents” shall mean
the Security Agreement and any other documents and filing required thereunder in order to grant the Purchasers a first priority security interest in the assets of the Company and the Subsidiaries as provided in the Security Agreement, including all
UCC-1 filing receipts. 
 “Short Sales” means all “short sales” as defined in Rule 200
of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).
 “Subscription Amount” means, as to each Purchaser, the aggregate amount to be paid for Debentures purchased hereunder as specified below such Purchaser’s name on the signature page
of this Agreement and next to the heading “Subscription Amount,” in United States dollars and in immediately available funds. 
 “Subsequent Closing” shall have the meaning ascribed to such term in Section 2.1. 
 “Subsequent Financing” shall have the meaning ascribed to such term in Section 4.12(a). 
 “Subsequent Financing Notice” shall have the meaning ascribed to such term in Section 4.12(b). 

“Termination Date” shall have the meaning ascribed to such term in Section 5.1. 

“Trading Day” means a day on which the principal Trading Market is open for trading. 

  
 5 

 “Trading Market” means any of the following markets or
exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE AMEX, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the OTC Bulletin Board
(or any successors to any of the foregoing). 
 “Transaction Documents” means this Agreement,
the Debentures, the Security Agreement, the Escrow Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions contemplated hereunder. 

Transfer Agent” means OTR, Inc., the current transfer agent of the Company, with a mailing address of 1001 SW
Fifth Avenue, Suite 1550, Portland, Oregon 97204-1143 and a facsimile number of (503) 273-9168, and any successor transfer agent of the Company. 
 “Underlying Shares” means the shares of Common Stock issued and issuable upon conversion or redemption of the Debentures. 

“Variable Rate Transaction” shall have the meaning ascribed to such term in Section 4.13.

 ARTICLE II. 
 PURCHASE AND SALE 
 2.1 Closing. On the Closing Date, upon the terms
and subject to the conditions set forth herein, substantially concurrent with the execution and delivery of this Agreement by the parties hereto, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, up to an
aggregate of $1,750,000 in principal amount of the Debentures. Each Purchaser shall deliver to the Escrow Agent, via wire transfer or a certified check, immediately available funds equal to such Purchaser’s Subscription Amount as set forth on
the signature page hereto executed by such Purchaser, and the Company shall deliver to each Purchaser its respective Debenture, as determined pursuant to Section 2.2(a), and the Company and each Purchaser shall deliver the other items set forth
in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the Closing shall occur at the offices of Taglich Brothers, Inc. or such other location as the parties shall
mutually agree. Notwithstanding anything in this Section to the contrary, in connection with any Debentures issued after the Closing Date that constitute an Exempt Issuance (a “Subsequent Closing”) and dated as of the date of such
Subsequent Closing, the Purchasers will be required only to deliver counterpart signature pages to this Agreement and to the Security Agreement, along with funds equal to the applicable Subscription Amount, whereupon the Company will be required to
deliver only a Debenture registered in the name of such Purchaser. At such time such additional purchaser shall be deemed a “Purchaser” hereunder and a “Secured Party” under the Security Agreement. 

  
 6 

 2.2 Deliveries. 

(a) On or prior to the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:

 (i) this Agreement duly executed by the Company; 

(ii) a legal opinion of Company Counsel, substantially in the form of Exhibit C attached hereto dated as of the
Closing Date; 
 (iii) a Debenture with a principal amount equal to such Purchaser’s Subscription Amount,
registered in the name of such Purchaser; and 
 (iv) the Security Agreement, duly executed by the Company, along
with all of the Security Documents, duly executed by the parties thereto. 
 (b) On or prior to the Closing Date,
each Purchaser shall deliver or cause to be delivered to the Company or the Escrow Agent, as applicable, the following: 
 (i) this Agreement duly executed by such Purchaser; 
 (ii) to
Escrow Agent, such Purchaser’s Subscription Amount by wire transfer to the account specified in the Escrow Agreement; and 
 (iii) the Security Agreement duly executed by such Purchaser. 
 2.3 Closing
Conditions. 
 (a) The obligations of the Company hereunder in connection with the Closing are subject to the
following conditions being met: 
 (i) the accuracy in all material respects on the Closing Date of the
representations and warranties of the Purchasers contained herein (unless as of a specific date therein in which case they shall be accurate as of such date); 
 (ii) all obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and 

(iii) the delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement. 

(b) The respective obligations of the Purchasers hereunder in connection with the Closing are subject to the following
conditions being met: 
 (i) the accuracy in all material respects when made and on the Closing Date of the
representations and warranties of the Company contained herein (unless as of a specific date therein); 
 (ii)
all obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed; 

  
 7 

 (iii) the delivery by the Company of the items set forth in
Section 2.2(a) of this Agreement; 
 (iv) there shall have been no Material Adverse Effect with respect to
the Company since the date hereof; and 
 (v) from the date hereof to the Closing Date, trading in the Common
Stock shall not have been suspended by the Commission or the Company’s principal Trading Market and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not have been suspended or limited,
or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities nor
shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the
reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Securities at the Closing. 

ARTICLE III. 
 REPRESENTATIONS AND WARRANTIES 
 3.1 Representations and Warranties of
the Company. Except as set forth in the SEC Reports or Disclosure Schedules, which Disclosure Schedules shall be deemed a part hereof and with the SEC Reports shall qualify any representation or otherwise made herein to the extent of the
disclosure contained in the corresponding section of the Disclosure Schedules or in the SEC Reports, the Company hereby makes the following representations and warranties to each Purchaser as of the Closing Date: 

(a) Organization and Qualification. The Company is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. The Company
is neither in violation nor default of any of the provisions of its certificate or articles of incorporation, bylaws or other organizational or charter documents. The Company is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not
have or reasonably be expected to result in: (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business, prospects or
condition (financial or otherwise) of the Company, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material respect on a timely basis its obligations under any

  
 8 

 
Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing
or seeking to revoke, limit or curtail such power and authority or qualification. 
 (b) Authorization;
Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations
hereunder and thereunder. The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by all
necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection herewith or therewith other than in connection with the Required Approvals. This
Agreement and each other Transaction Document to which it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof and thereof, will constitute the valid and binding
obligation of the Company enforceable against the Company in accordance with its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general
application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and
contribution provisions may be limited by applicable law. 
 (c) No Conflicts. The execution, delivery and
performance by the Company of this Agreement and the other Transaction Documents to which it is a party, the issuance and sale of the Securities and the consummation by it of the transactions contemplated hereby and thereby do not and will not:
(i) conflict with or violate any provision of the Company’s certificate or articles of incorporation, bylaws or other organizational or charter documents, (ii) conflict with, or constitute a default (or an event that with notice or
lapse of time or both would become a default) under, result in the creation of any Lien upon any of the properties or assets of the Company other than as contemplated by the Transaction Documents, or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument (evidencing a Company debt or otherwise) or other understanding to which the Company is a party or
by which any property or asset of the Company is bound or affected, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any
court or governmental authority to which the Company is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company is bound or affected; except in the case of each of clauses (ii) and
(iii), such as could not have or reasonably be expected to result in a Material Adverse Effect. 
 (d)
Filings, Consents and Approvals. The Company is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority 

  
 9 

 
or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents, which has not been obtained, given or made, other than: (i) the
filings required pursuant to Section 4.6 of this Agreement, and (ii) the filing of Form D with the Commission and such filings as are required to be made under applicable state securities laws (collectively, the “Required
Approvals”). 
 (e) Issuance of the Securities. The Securities are duly authorized and, when
issued and paid for in accordance with the applicable Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the
Transaction Documents. The Underlying Shares, when issued in accordance with the terms of the Transaction Documents, will be validly issued, fully paid and nonassessable, free and clear of all Liens imposed by the Company other than restrictions on
transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock a number of shares of Common Stock for issuance of the Underlying Shares at least equal to the Required Minimum on the date hereof.

 (f) Capitalization. The capitalization of the Company is as set forth on Schedule 3.1(f), which
Schedule 3.1(f) shall also include the number of shares of Common Stock owned beneficially, and of record, by Affiliates of the Company as of the date hereof. The Company has not issued any capital stock since its most recently filed periodic
report under the Exchange Act, other than pursuant to the exercise of employee stock options under the Company’s stock option plans, the issuance of shares of Common Stock to employees pursuant to the Company’s employee stock purchase
plans and pursuant to the conversion and/or exercise of Common Stock Equivalents outstanding as of the date of the most recently filed periodic report under the Exchange Act. No Person has any right of first refusal, preemptive right, right of
participation, or any similar right to participate in the transactions contemplated by the Transaction Documents. Except as a result of the purchase and sale of the Securities, there are no outstanding options, warrants, scrip rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire any shares of Common Stock, or
contracts, commitments, understandings or arrangements by which the Company is or may become bound to issue additional shares of Common Stock or Common Stock Equivalents. The issuance and sale of the Securities will not obligate the Company to issue
shares of Common Stock or other securities to any Person (other than the Purchasers) and, other than as set forth on Schedule 3.1(f), will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange
or reset price under any of such securities. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid and nonassessable, have been issued in compliance with all federal and state securities laws,
and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for
the issuance and sale of the Securities. There are no stockholders agreements, voting agreements or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of the Company,
between or among any of the Company’s stockholders. 

  
 10 

 (g) SEC Reports; Financial Statements. The Company has filed all
reports, schedules, forms, statements and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or
such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the
“SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in
all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be
stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act. The financial
statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing except as set forth
on Schedule 3.1(g). Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”), except as may be
otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
and its consolidated Subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, year-end audit adjustments, which are not expected to
be material. 
 (h) Material Changes; Undisclosed Events, Liabilities or Developments. Except as set forth
on Schedule 3.1(h), since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof: (i) there has been no event,
occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued
expenses incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission,
(iii) the Company has not altered its method of accounting, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase or
redeem any shares of its capital stock and (v) the Company has not issued any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans. The Company does not have pending before the
Commission any request for confidential treatment of information. Except for the issuance of the Securities 

  
 11 

 
contemplated by this Agreement or as set forth on Schedule 3.1(h), no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected to
occur or exist with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial condition, that would be required to be disclosed by the Company under applicable securities laws at the time
this representation is made or deemed made that has not been publicly disclosed at least 1 Trading Day prior to the date that this representation is made. 
 (i) Litigation. There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, or any
of its properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”) which (i) adversely affects or
challenges the legality, validity or enforceability of any of the Transaction Documents or the Securities or (ii) could, if there were an unfavorable decision, have or reasonably be expected to result in a Material Adverse Effect. Neither the
Company nor any director or officer, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of
the Company, there is not pending or contemplated, any investigation by the Commission involving the Company or any current or former director or officer of the Company. The Commission has not issued any stop order or other order suspending the
effectiveness of any registration statement filed by the Company under the Exchange Act or the Securities Act. 

(j) Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any
of the employees of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s employees is a member of a union that relates to such employee’s relationship with the Company, and the
Company is not a party to a collective bargaining agreement, and the Company and believes that is relationships with its employees are good. To the knowledge of the Company, no executive officer of the Company, is, or is now expected to be, in
violation of any material term of any employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third party, and
the continued employment of each such executive officer does not subject the Company to any liability with respect to any of the foregoing matters. The Company is in compliance with all U.S. federal, state, local and foreign laws and regulations
relating to employment and employment practices, terms and conditions of employment and wages and hours, except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. 
 (k) Compliance. The Company: (i) is not in default under or in violation of (and no event
has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company), nor has the Company received notice of a claim that it is in default under or that it is in violation of, any indenture,
loan or credit agreement or any other agreement or instrument to which it is a party or by which it or 

  
 12 

 
any of its properties is bound (whether or not such default or violation has been waived), (ii) is not in violation of any judgment, decree or order of any court, arbitrator or other
governmental authority or (iii) is not or has not been in violation of any statute, rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws relating to taxes,
environmental protection, occupational health and safety, product quality and safety and employment and labor matters, except in each case as could not have or reasonably be expected to result in a Material Adverse Effect. 

(l) Regulatory Permits. The Company possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct its business as described in the SEC Reports, except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect
(“Material Permits”), and the Company has not received any notice of proceedings relating to the revocation or modification of any Material Permit. 

(m) Title to Assets. The Company has good and marketable title in fee simple to all real property owned by it and
good and marketable title in all personal property owned by it that is material to the business of the Company, in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not
materially interfere with the use made and proposed to be made of such property by the Company and (ii) Liens for the payment of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and,
the payment of which is neither delinquent nor subject to penalties. Any real property and facilities held under lease by the Company are held by it under valid, subsisting and enforceable leases with which the Company is in compliance. 

(n) Intellectual Property. The Company has, or has rights to use, all patents, patent applications, trademarks,
trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses and other intellectual property rights and similar rights as described in the SEC Reports as necessary or required for use in connection with its
business and which the failure to so have could have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). The Company has not received a notice (written or otherwise) that any of, the Intellectual Property
Rights has expired, terminated or been abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. The Company has not received, since the date of the latest audited financial
statements included within the SEC Reports, a written notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person, except as could not have or reasonably be expected to not
have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The Company has taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect. 

  
 13 

 (o) Insurance. The Company is insured by insurers of recognized
financial responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which the Company is engaged, including, but not limited to, directors and officers insurance coverage at least equal to the
aggregate Subscription Amount. The Company does not have any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be
necessary to continue its business without a significant increase in cost. 
 (p) Transactions With Affiliates
and Employees. Except as set forth in the SEC Reports, none of the officers or directors of the Company and, to the knowledge of the Company, none of the employees of the Company is presently a party to any transaction with the Company (other
than for services as employees, officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real or personal property to or from providing for the
borrowing of money from or lending of money to, or otherwise requiring payments to or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any such employee has a substantial
interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred on
behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company. 
 (q) Sarbanes-Oxley; Internal Accounting Controls. The Company is in compliance with any and all applicable requirements of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof,
and any and all applicable rules and regulations promulgated by the Commission thereunder that are effective as of the date hereof and as of the Closing Date. Other than the material weakness identified by the Company in its Annual Report for the
fiscal year ending December 31, 2010, the Company maintains a system of internal accounting controls sufficient to provide reasonable assurance that: (i) transactions are executed in accordance with management’s general or specific
authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets is permitted only in accordance with
management’s general or specific authorization, and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. The Company has
established disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the
reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the effectiveness
of the disclosure controls and procedures of the Company as of the end of the period covered by the most recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most
recently filed 

  
 14 

 
periodic report under the Exchange Act the conclusions of the certifying officers about the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation
Date. Other than as identified in the most recently filed periodic report under the Exchange Act, since the Evaluation Date, there has been no change in the internal control over financial reporting (as such term is defined in the Exchange Act) that
has materially affected, or is reasonably likely to materially affect, the internal control over financial reporting of the Company. 
 (r) Certain Fees. Other than Taglich Brothers, Inc., no brokerage or finder’s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder,
placement agent, investment banker, bank or other Person with respect to the transactions contemplated by the Transaction Documents. The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf
of other Persons for fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Transaction Documents. 
 (s) Private Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer
and sale of the Securities by the Company to the Purchasers as contemplated hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Trading Market. 

(t) Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment
for the Securities, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an
“investment company” subject to registration under the Investment Company Act of 1940, as amended. 

(u) Registration Rights. Except as set forth on Schedule 3.1(u), no Person has any right to cause the
Company to effect the registration under the Securities Act of any securities of the Company. 
 (v) Listing
and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating such registration. Other than in connection with the Company’s removal from the NYSE Amex
Exchange, the Company has not, in the 12 months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or
maintenance requirements of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. 

  
 15 

 (w) Application of Takeover Protections. The Company and the Board of
Directors have taken all necessary action, if any, in order to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under
the Company’s certificate of incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations
or exercising their rights under the Transaction Documents, including without limitation as a result of the Company’s issuance of the Securities and the Purchasers’ ownership of the Securities. 

(x) Disclosure. Except with respect to the material terms and conditions of the transactions contemplated by the
Transaction Documents and otherwise as set forth in the Disclosure Schedules, the Company confirms that neither it nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that it
believes constitutes or might constitute material, non-public information. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting transactions in securities of the Company. All of the
disclosure furnished by or on behalf of the Company to the Purchasers regarding the Company, its businesses and the transactions contemplated hereby, including the Disclosure Schedules to this Agreement, is true and correct and does not contain any
untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. As of the respective dates, the press releases
disseminated by the Company during the twelve months preceding the date of this Agreement, taken as a whole, together with the SEC Reports, did not contain any untrue statement of a material fact or omit to state a material fact required to be
stated therein or necessary in order to make the statements therein, in light of the circumstances under which they were made and when made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations
or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof. 
 (y) No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor any
Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with prior
offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any
of the securities of the Company are listed or designated. 
 (z) Indebtedness. Schedule 3.1(z)
sets forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company, or for which the Company has commitments. For the purposes of this Agreement, “Indebtedness” means (x) any liabilities for
borrowed money or amounts owed in excess of $50,000 (other than 

  
 16 

 
trade accounts payable incurred in the ordinary course of business), (y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not
the same are or should be reflected in the Company’s consolidated balance sheet (or the notes thereto), except guaranties by endorsement of negotiable instruments for deposit or collection or similar transactions in the ordinary course of
business; and (z) the present value of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. The Company is not in default with respect to any Indebtedness. 

(aa) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be
expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required
by any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside
on its books provision reasonably adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply. There are no unpaid taxes in any material amount claimed to be due by the
taxing authority of any jurisdiction, and the officers of the Company know of any basis for any such claim. 

(bb) No General Solicitation. Neither the Company nor, to the Company’s knowledge, any person acting on behalf
of the Company has offered or sold any of the Securities by any form of general solicitation or general advertising. The Company has offered the Securities for sale only to the Purchasers and certain other “accredited investors” within the
meaning of Rule 501 under the Securities Act. 
 (cc) Foreign Corrupt Practices. Neither the Company, nor,
to the knowledge of the Company, any agent or other person acting on behalf of the Company, has: (i) directly or indirectly, used any funds for unlawful contributions, gifts, entertainment or other unlawful expenses related to foreign or
domestic political activity, (ii) made any unlawful payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate funds, (iii) failed to disclose fully any
contribution made by the Company (or made by any person acting on its behalf of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of the Foreign Corrupt Practices Act of 1977, as
amended. 
 (dd) Accountants. The Company’s accounting firm is set forth on Schedule 3.1(dd)
of the Disclosure Schedules. To the knowledge and belief of the Company, such accounting firm is a registered public accounting firm as required by the Exchange Act. 

(ee) Seniority. As of the Closing Date, no Indebtedness or other claim against the Company is senior to the
Debentures in right of payment, whether with respect to interest or upon liquidation or dissolution, or otherwise, other than indebtedness secured by purchase money security interests (which is senior only as to underlying assets

  
 17 

 
covered thereby), capital lease obligations (which is senior only as to the property covered thereby) and obligations to the Company’s employees under applicable statutory payroll
requirements. 
 (ff) No Disagreements with Accountants and Lawyers. There are no disagreements of any
kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company is current with respect to any fees owed to its accountants
and lawyers which could affect the Company’s ability to perform any of its obligations under any of the Transaction Documents. 
 (gg) Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm’s length
purchaser with respect to the Transaction Documents and the transactions contemplated thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect
to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions contemplated thereby
is merely incidental to the Purchasers’ purchase of the Securities. The Company further represents to each Purchaser that the Company’s decision to enter into this Agreement and the other Transaction Documents has been based solely on the
independent evaluation of the transactions contemplated hereby by the Company and its representatives. 
 (hh)
Acknowledgment Regarding Purchaser’s Trading Activity. Anything in this Agreement or elsewhere herein to the contrary notwithstanding (except for Sections 3.2(f) and 4.15 hereof), it is understood and acknowledged by the Company that:
(i) none of the Purchasers has been asked by the Company to agree, nor has any Purchaser agreed, to desist from purchasing or selling, long and/or short, securities of the Company, or “derivative” securities based on securities issued
by the Company or to hold the Securities for any specified term, (ii) past or future open market or other transactions by any Purchaser, specifically including, without limitation, Short Sales or “derivative” transactions, before or
after the closing of this or future private placement transactions, may negatively impact the market price of the Company’s publicly-traded securities, (iii) any Purchaser, and counter-parties in “derivative” transactions to
which any such Purchaser is a party, directly or indirectly, may presently have a “short” position in the Common Stock and (iv) each Purchaser shall not be deemed to have any affiliation with or control over any arm’s length
counter-party in any “derivative” transaction. The Company acknowledges that such aforementioned hedging activities do not constitute a breach of any of the Transaction Documents. The Company further understands and acknowledges that
(y) one or more Purchasers may engage in hedging activities at various times during the period that the Securities are outstanding, including, without limitation, during the periods that the value of the Underlying Shares deliverable with
respect to Securities are being determined, and (z) such hedging activities (if any) could reduce the value of the existing stockholders’ equity interests in the Company at and after the time that the hedging activities are being
conducted. 

  
 18 

 (ii) Regulation M Compliance. The Company has not, and to its
knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of any of
the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay to any Person any compensation for soliciting another to purchase any other
securities of the Company, other than, in the case of clauses (ii) and (iii), compensation paid to the Company’s placement agent in connection with the placement of the Securities. 

(jj) FDA. As to each product subject to the jurisdiction of the U.S. Food and Drug Administration
(“FDA”) under the Federal Food, Drug and Cosmetic Act, as amended, and the regulations thereunder (“FDCA”) that is manufactured, packaged, labeled, tested, distributed, sold, and/or marketed by the Company or any of
its Subsidiaries (each such product, a “Pharmaceutical Product”), such Pharmaceutical Product is being manufactured, packaged, labeled, tested, distributed, sold and/or marketed by the Company in compliance with all applicable
requirements under FDCA and similar laws, rules and regulations relating to registration, investigational use, premarket clearance, licensure, or application approval, good manufacturing practices, good laboratory practices, good clinical practices,
product listing, quotas, labeling, advertising, record keeping and filing of reports, except where the failure to be in compliance would not have a Material Adverse Effect. There is no pending, completed or, to the Company’s knowledge,
threatened, action (including any lawsuit, arbitration, or legal or administrative or regulatory proceeding, charge, complaint, or investigation) against the Company or any of its Subsidiaries, and none of the Company or any of its Subsidiaries has
received any notice, warning letter or other communication from the FDA or any other governmental entity, which (i) contests the premarket clearance, licensure, registration, or approval of, the uses of, the distribution of, the manufacturing
or packaging of, the testing of, the sale of, or the labeling and promotion of any Pharmaceutical Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or
sales promotional materials relating to, any Pharmaceutical Product, (iii) imposes a clinical hold on any clinical investigation by the Company or any of its Subsidiaries, (iv) enjoins production at any facility of the Company or any of
its Subsidiaries, (v) enters or proposes to enter into a consent decree of permanent injunction with the Company or any of its Subsidiaries, or (vi) otherwise alleges any violation of any laws, rules or regulations by the Company or any of
its Subsidiaries, and which, either individually or in the aggregate, would have a Material Adverse Effect. The properties, business and operations of the Company have been and are being conducted in all material respects in accordance with all
applicable laws, rules and regulations of the FDA. The Company has not been informed by the FDA that the FDA will prohibit the marketing, sale, license or use in the United States of any product proposed to be developed, produced or marketed by
the Company nor, except as set forth on Schedule 3.1(jj), has the FDA expressed any concern as to approving or clearing for marketing any product being developed or proposed to be developed by the Company. 

  
 19 

 (kk) Stock Option Plans. Each stock option granted by the Company
under the Company’s stock option plan was granted (i) in accordance with the terms of the Company’s stock option plan and (ii) with an exercise price at least equal to the fair market value of the Common Stock on the date such
stock option would be considered granted under GAAP and applicable law. No stock option granted under the Company’s stock option plan has been backdated. The Company has not knowingly granted, and there is no and has been no Company policy or
practice to knowingly grant, stock options prior to, or otherwise knowingly coordinate the grant of stock options with, the release or other public announcement of material information regarding the Company or its Subsidiaries or their financial
results or prospects. 
 (ll) Office of Foreign Assets Control. Neither the Company nor, to the
Company’s knowledge, any director, officer, agent, employee or affiliate of the Company is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 (mm) U.S. Real Property Holding Corporation. The Company is not and has never been a U.S. real property
holding corporation within the meaning of Section 897 of the Internal Revenue Code of 1986, as amended, and the Company shall so certify upon Purchaser’s request. 

(nn) Bank Holding Company Act. Neither the Company nor any of its Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the “Federal Reserve”). Neither the Company nor any of its Affiliates owns or controls, directly or
indirectly, five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent or more of the total equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve.
Neither the Company nor any of its Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. 

(oo) Money Laundering. The operations of the Company are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the
“Money Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Money Laundering Laws is pending or, to the
knowledge of the Company, threatened. 

  
 20 

 3.2 Representations and Warranties of the Purchasers. Each Purchaser, for itself and
for no other Purchaser, hereby represents and warrants as of the date hereof and as of the Closing Date to the Company as follows (unless as of a specific date therein): 

(a) Organization; Authority. Such Purchaser is either an individual or an entity duly incorporated or formed,
validly existing and in good standing under the laws of the jurisdiction of its incorporation or formation with full individual right, or corporate, partnership, limited liability company or similar power and authority to enter into and to
consummate the transactions contemplated by the Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions
contemplated by the Transaction Documents have been duly authorized by all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which such Purchaser
is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its
terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as
limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. 

(b) Own Account. Such Purchaser understands that the Securities are “restricted securities” and have not
been registered under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation
of the Securities Act or any applicable state securities law, has no present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or
understandings with any other persons to distribute or regarding the distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right
to sell the Securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. 

(c) Purchaser Status. At the time such Purchaser was offered the Securities, it was, and as of the date hereof it
is, and on each date on which it converts any Debentures it will be either: (i) an “accredited investor” as defined in Rule 501 under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule
144A(a) under the Securities Act. Such Purchaser is not required to be registered as a broker-dealer under Section 15 of the Exchange Act. 
 (d) Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business

  
 21 

 
and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such
Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such investment. 
 (e) General Solicitation. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities published in any
newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement. 

(f) Certain Transactions and Confidentiality. Other than consummating the transactions contemplated hereunder, such
Purchaser has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, executed any purchases or sales, including Short Sales, of the securities of the Company during the period
commencing as of the time that such Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending
immediately prior to the execution hereof. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the
portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets
managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement, such Purchaser has maintained the confidentiality of all disclosures made
to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any
actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future. 
 The Company acknowledges and agrees that the representations contained in Section 3.2 shall not modify, amend or affect such Purchaser’s right to rely on the Company’s representations and
warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in connection with this Agreement or the consummation of the
transaction contemplated hereby. 
 ARTICLE IV. 
 OTHER AGREEMENTS OF THE PARTIES 
 4.1 Transfer Restrictions.

 (a) The Securities may only be disposed of in compliance with state and federal securities laws. In connection
with any transfer of Securities other than pursuant 

  
 22 

 
to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in connection with a pledge as contemplated in Section 4.1(b), the Company may, before
effecting such transfer on its books and records, require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be
reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the
terms of this Agreement and shall have the rights and obligations of a Purchaser under this Agreement. 
 (b) The
Purchasers agree to the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in substantially the following form: 
 [NEITHER] THIS SECURITY [NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE] HAS [NOT] BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN
RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT
OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE COMPANY. THIS SECURITY [AND THE SECURITIES ISSUABLE UPON CONVERSION OF THIS SECURITY] MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT WITH A REGISTERED
BROKER-DEALER OR OTHER LOAN WITH A FINANCIAL INSTITUTION THAT IS AN “ACCREDITED INVESTOR” AS DEFINED IN RULE 501(a) UNDER THE SECURITIES ACT OR OTHER LOAN SECURED BY SUCH SECURITIES. 

The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement
with a registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and who agrees to be bound by the
provisions of this Agreement and, if required under the terms of such arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the
Company and no legal opinion of legal counsel of the pledgee, secured party or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser’s expense, the Company will
execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities. 

  
 23 

 (c) Certificates evidencing the Underlying Shares shall not contain any
legend (including the legend set forth in Section 4.1(b) hereof): (i) while a registration statement covering the resale of such security is effective under the Securities Act, (ii) following any sale of such Underlying Shares
pursuant to Rule 144, (iii) if such Underlying Shares are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Underlying Shares and
without volume or manner-of-sale restrictions or (iv) the securities are no longer “restricted securities” under applicable requirements of the Securities Act. The Company shall cause its counsel to issue a legal opinion to the
Transfer Agent promptly after the Effective Date if required by the Transfer Agent to effect the removal of the legend hereunder. If all or any portion of a Debenture is converted at a time when there is an effective registration statement to cover
the resale of the Underlying Shares, or if such Underlying Shares may be sold under Rule 144 and the Company is then in compliance with the current public information required under Rule 144, or if such Underlying Shares may be sold under Rule 144
without the requirement for the Company to be in compliance with the current public information required under Rule 144 as to such Underlying Shares and without volume or manner-of-sale restrictions or if the securities are no longer
“restricted securities,” then such Underlying Shares shall be issued free of all legends. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section 4.1(c), it will, no
later than three Trading Days following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate representing Underlying Shares, as applicable, issued with a restrictive legend (such third Trading Day, the “Legend
Removal Date”), deliver or cause to be delivered to such Purchaser a certificate representing such shares that is free from all restrictive and other legends. The Company may not make any notation on its records or give instructions to the
Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Certificates for Underlying Shares subject to legend removal hereunder shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of
the Purchaser’s prime broker with the Depository Trust Company System as directed by such Purchaser. 
 (d)
Each Purchaser, severally and not jointly with the other Purchasers, agrees with the Company that such Purchaser will sell any Securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus
delivery requirements, or an exemption therefrom, and that if Securities are sold pursuant to a registration statement, they will be sold in compliance with the plan of distribution set forth therein, and acknowledges that the removal of the
restrictive legend from certificates representing Securities as set forth in this Section 4.1 is predicated upon the Company’s reliance upon this understanding. 
 4.2 Acknowledgment of Dilution. The Company acknowledges that the issuance of the Securities may result in substantial dilution of the outstanding shares of Common Stock. The Company further
acknowledges that its obligations under the Transaction Documents, including, without limitation, its obligation to issue the Underlying Shares pursuant to the Transaction Documents, are unconditional and absolute and not subject to any right of set
off, counterclaim, delay or reduction, regardless of the effect of any such dilution or any claim the Company may have against any Purchaser and regardless of the dilutive effect that such issuance may have on the ownership of the other stockholders
of the Company. 

  
 24 

 4.3 Furnishing of Information; Public Information. 

(a) If the Common Stock is not registered under Section 12(b) or 12(g) of the Exchange Act on the date hereof,
the Company agrees to cause the Common Stock to be registered under Section 12(g) of the Exchange Act on or before the 60th calendar day following the date hereof. Until the earliest of the time that no Purchaser owns Securities, the Company
covenants to maintain the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be
filed by the Company after the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act. 

(b) At any time during the period commencing from the six (6) month anniversary of the date hereof and ending at
such time that all of the Securities may be sold without the requirement for the Company to be in compliance with Rule 144(c)(1) and otherwise without restriction or limitation pursuant to Rule 144, if the Company shall fail for any reason to
satisfy the current public information requirement under Rule 144(c) (a “Public Information Failure”) then, in addition to such Purchaser’s other available remedies, the Company shall pay to a Purchaser, in cash, as partial
liquidated damages and not as a penalty, by reason of any such delay in or reduction of its ability to sell the Securities, an amount in cash equal to two percent (2.0%) of the aggregate Subscription Amount of such Purchaser’s Securities
on the day of a Public Information Failure and on every thirtieth (30th) day (pro rated for periods totaling less than thirty days) thereafter until the earlier of (a) the date such Public Information Failure is cured and (b) such time that such public
information is no longer required for the Purchasers to transfer the Underlying Shares pursuant to Rule 144. The payments to which a Purchaser shall be entitled pursuant to this Section 4.3(b) are referred to herein as “Public
Information Failure Payments.” Public Information Failure Payments shall be paid on the earlier of (i) the last day of the calendar month during which such Public Information Failure Payments are incurred and (ii) the third
(3rd) Business Day after the event or failure giving
rise to the Public Information Failure Payments is cured. In the event the Company fails to make Public Information Failure Payments in a timely manner, such Public Information Failure Payments shall bear interest at the rate of 1.5% per month
(prorated for partial months) until paid in full. Nothing herein shall limit such Purchaser’s right to pursue actual damages for the Public Information Failure, and such Purchaser shall have the right to pursue all remedies available to it at
law or in equity including, without limitation, a decree of specific performance and/or injunctive relief. 
 4.4
Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the
Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market
such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction. 

  
 25 

 4.5 Conversion Procedures. The Form of Notice of Conversion included in the
Debentures set forth the totality of the procedures required of the Purchasers in order to convert the Debentures. No additional legal opinion, other information or instructions shall be required of the Purchasers to convert their Debentures. The
Company shall honor conversions of the Debentures and shall deliver Underlying Shares in accordance with the terms, conditions and time periods set forth in the Transaction Documents. 

4.6 Securities Laws Disclosure; Publicity. The Company shall, by 9:00 a.m. (New York City time) on the Trading Day immediately
following the date hereof, file a Current Report on Form 8-K and press release disclosing the material terms of the transactions contemplated hereby. From and after the issuance of such press release, the Company represents to the Purchasers that it
shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the transactions
contemplated by the Transaction Documents. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue
any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of
the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or
communication. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the Commission or any regulatory agency or Trading Market, without the prior
written consent of such Purchaser, except: (a) as required by federal securities law in connection with the filing of final Transaction Documents (including signature pages thereto) with the Commission and (b) to the extent such disclosure
is required by law or Trading Market regulations or included in the request of any self-regulatory agency, in which case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (b) to the extent
permitted under applicable law or Trading Market regulation. 
 4.7 Shareholder Rights Plan. No claim will be made or
enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights
agreement) or similar anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the
Transaction Documents or under any other agreement between the Company and such Purchaser. 
 4.8 Non-Public Information.
Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, the Company covenants and agrees that neither it, nor any other Person acting on its behalf, will provide any Purchaser or its
agents or counsel with any information that the Company believes constitutes material non-public information, unless prior thereto such Purchaser shall have entered into a written agreement with the Company regarding the confidentiality and use of
such information. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. 

  
 26 

 4.9 Use of Proceeds. Except as set forth on Schedule 4.9 attached
hereto, the Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes and shall not use such proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than payment of
trade payables in the ordinary course of the Company’s business and prior practices), (b) for the redemption of any Common Stock or Common Stock Equivalents, (c) for the settlement of any outstanding litigation or (d) in
violation of FCPA or OFAC regulations. 
 4.10 Indemnification of Purchasers. Subject to the provisions of this
Section 4.10, the Company will indemnify and hold each Purchaser and its directors, officers, shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles
notwithstanding a lack of such title or any other title), each Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders,
agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser
Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of
investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction
Documents or (b) any action instituted against the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Party, with respect to any of the
transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such
Purchaser Party may have with any such stockholder or any violations by such Purchaser Party of state or federal securities laws or any conduct by such Purchaser Party which constitutes fraud, gross negligence, willful misconduct or malfeasance). If
any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the
defense thereof with counsel of its own choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) such employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in
which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any 

  
 27 

 
Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or
delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by such Purchaser Party
in this Agreement or in the other Transaction Documents. The indemnification required by this Section 4.10 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are
received or are incurred. The indemnity agreements contained herein shall be in addition to any cause of action or similar right of any Purchaser Party against the Company or others under applicable law. 

4.11 Reservation and Listing of Securities. 

(a) The Company shall maintain a reserve from its duly authorized shares of Common Stock for issuance pursuant to the
Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents. 
 (b) If, on any date, the number of authorized but unissued (and otherwise unreserved) shares of Common Stock is less than the Required Minimum on such date, then the Board of Directors shall use
commercially reasonable efforts to amend the Company’s certificate or articles of incorporation to increase the number of authorized but unissued shares of Common Stock to at least the Required Minimum at such time, as soon as possible and in
any event not later than the 75th day after such date. 
 4.12 Participation in Future Financing. 

(a) From the date hereof until the date that the Debentures owned by any particular Purchaser are no longer outstanding,
upon any issuance by the Company or any of its Subsidiaries of Common Stock, Common Stock Equivalents for cash consideration, Indebtedness or a combination of units hereof (a “Subsequent Financing”), each Purchaser shall have the
right to participate in up to an amount of the Subsequent Financing that permits the Purchaser to own the same percentage of the Company on a fully diluted basis immediately following such Subsequent Financing as the Purchaser owned immediately
preceding such Subsequent Financing (the “Participation Maximum”) on the same terms, conditions and price provided for in the Subsequent Financing. 

(b) At least five (5) Trading Days prior to the closing of the Subsequent Financing, the Company shall deliver to
each Purchaser a written notice of its intention to effect a Subsequent Financing (“Pre-Notice”), which Pre-Notice shall ask such Purchaser if it wants to review the details of such financing (such additional notice, a
“Subsequent Financing Notice”). Upon the request of a Purchaser, and only upon a request by such Purchaser, for a Subsequent Financing Notice, the Company shall promptly, but no later than one (1) Trading Day after such
request, deliver a Subsequent Financing Notice to such Purchaser. The Subsequent Financing Notice shall describe in reasonable detail the proposed terms of such Subsequent Financing, the amount of proceeds intended to be

  
 28 

 
raised thereunder and the Person or Persons through or with whom such Subsequent Financing is proposed to be effected and shall include a term sheet or similar document relating thereto as an
attachment. 
 (c) Any Purchaser desiring to participate in such Subsequent Financing must
provide written notice to the Company by not later than 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Purchasers have received the Pre-Notice that such Purchaser is willing to participate in the Subsequent Financing, the amount of such Purchaser’s participation,
and representing and warranting that such Purchaser has such funds ready, willing, and available for investment on the terms set forth in the Subsequent Financing Notice. If the Company receives no such notice from a Purchaser as of such fifth
(5th) Trading Day, such Purchaser shall be deemed to
have notified the Company that it does not elect to participate. 
 (d) If by 5:30 p.m. (New
York City time) on the fifth (5th ) Trading Day after all
of the Purchasers have received the Pre-Notice, notifications by the Purchasers of their willingness to participate in the Subsequent Financing (or to cause their designees to participate) is, in the aggregate, less than the total amount of the
Subsequent Financing, then the Company may effect the remaining portion of such Subsequent Financing on the terms and with the Persons set forth in the Subsequent Financing Notice. 

(e) If by 5:30 p.m. (New York City time) on the fifth (5th) Trading Day after all of the Purchasers have received the
Pre-Notice, the Company receives responses to a Subsequent Financing Notice from Purchasers seeking to purchase more than the aggregate amount of the Participation Maximum, each such Purchaser shall have the right to purchase its Pro Rata Portion
(as defined below) of the Participation Maximum. “Pro Rata Portion” means the ratio of (x) the Subscription Amount of Securities purchased on the Closing Date by a Purchaser participating under this Section 4.12 and
(y) the sum of the aggregate Subscription Amounts of Securities purchased on the Closing Date by all Purchasers participating under this Section 4.12 plus the aggregate subscription amounts of investors party to securities purchase
agreement(s) contemplated by clause (d) in the definition of Exempt Issuance that are participating in such Subsequent Financing pursuant to participation rights granted to such investors under such agreements that are substantially similar to
this Section 4.12. 
 (f) The Company must provide the Purchasers with a second Subsequent Financing Notice,
and the Purchasers will again have the right of participation set forth above in this Section 4.12, if the Subsequent Financing subject to the initial Subsequent Financing Notice is not consummated for any reason on the terms set forth in such
Subsequent Financing Notice within thirty (30) Trading Days after the date of the initial Subsequent Financing Notice. 
 (g) Notwithstanding the foregoing, this Section 4.12 shall not apply in respect of (i) an Exempt Issuance, or (ii) an underwritten public offering of Common Stock. 

  
 29 

 4.13 Subsequent Equity Sales. From the date hereof until such time as no Purchaser
holds any of the Debentures, the Company shall be prohibited from effecting or entering into an agreement to effect any issuance by the Company or any of its Subsidiaries of Common Stock or Common Stock Equivalents for cash consideration (or a
combination of units thereof) involving a Variable Rate Transaction. “Variable Rate Transaction” means a transaction in which the Company (i) issues or sells any debt or equity securities that are convertible into, exchangeable
or exercisable for, or include the right to receive, additional shares of Common Stock either (A) at a conversion price, exercise price or exchange rate or other price that is based upon, and/or varies with, the trading prices of or quotations
for the shares of Common Stock at any time after the initial issuance of such debt or equity securities or (B) with a conversion, exercise or exchange price that is subject to being reset at some future date after the initial issuance of such
debt or equity security or upon the occurrence of specified or contingent events directly or indirectly related to the business of the Company or the market for the Common Stock or (ii) enters into any agreement, including, but not limited to,
an equity line of credit, whereby the Company may sell securities at a future determined price. Any Purchaser shall be entitled to obtain injunctive relief against the Company to preclude any such issuance, which remedy shall be in addition to any
right to collect damages. Notwithstanding the foregoing, this Section 4.13 shall not apply in respect of an Exempt Issuance, except that no Variable Rate Transaction shall be an Exempt Issuance. 

4.14 Equal Treatment of Purchasers. No consideration (including any modification of any Transaction Document) shall be offered or
paid to any Person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. Further, the Company shall not
make any payment of principal or interest on the Debentures in amounts which are disproportionate to the respective principal amounts outstanding on the Debentures at any applicable time. For clarification purposes, this provision constitutes a
separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended for the Company to treat the Purchasers as a class and shall not in any way be construed as the Purchasers acting in concert or as a
group with respect to the purchase, disposition or voting of Securities or otherwise. 
 4.15 Certain Transactions and
Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short
Sales, of any of the Company’s securities during the period commencing with the execution of this Agreement and ending at such time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press
release as described in Section 4.6. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to
the initial press release as described in Section 4.6, such Purchaser will maintain the confidentiality of the existence and terms of this transaction and the information included in the Transaction Documents and the Disclosure Schedules.
Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser makes any representation, warranty or covenant hereby that it will not
engage in effecting transactions in any securities of the Company after the 

  
 30 

 
time that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.6, (ii) no Purchaser shall be
restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that the transactions contemplated by this Agreement are first publicly announced
pursuant to the initial press release as described in Section 4.6 and (iii) no Purchaser shall have any duty of confidentiality to the Company or its Subsidiaries after the issuance of the initial press release as described in
Section 4.6. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have
no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the covenant set forth above shall only apply with respect to the portion of assets managed by the portfolio
manager that made the investment decision to purchase the Securities covered by this Agreement. 
 4.16 Form D; Blue Sky
Filings. The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall
reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall
provide evidence of such actions promptly upon request of any Purchaser. 
 4.17 Capital Changes. Until the one year
anniversary of the Closing Date, other than for purposes of qualifying for initial listing on the National Securities Exchange or meeting the continued listing requirements of such exchange, the Company shall not undertake a reverse or forward stock
split or reclassification of the Common Stock without the prior written consent of the Purchasers holding a majority in principal amount outstanding of the Debentures. 
 ARTICLE V. 
 MISCELLANEOUS 

5.1 Termination. This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only
and without any effect whatsoever on the obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before June 30, 2011 (the “Termination
Date”); provided, however, that such termination will not affect the right of any party to sue for any breach by any other party (or parties). 
 5.2 Fees and Expenses. At the Closing, the Company has agreed to reimburse Taglich Brothers, Inc. the actual expense of up to $10,000 and Hudson Securities, Inc. (its former co-placement agent) for
its certain fees and expenses, $15,000 of which has been paid prior to the Closing. Except as expressly set forth in the Transaction Documents to the contrary, each party shall pay the fees and expenses of its advisers, counsel, accountants and
other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees, stamp taxes and other taxes and
duties levied in connection with the delivery of any Securities to the Purchasers. 

  
 31 

 5.3 Entire Agreement. The Transaction Documents, together with the exhibits and
schedules thereto, contain the entire understanding of the parties with respect to the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties
acknowledge have been merged into such documents, exhibits and schedules. 
 5.4 Notices. Any and all
notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of: (a) the date of transmission, if such notice or communication is
delivered via facsimile at the facsimile number or e-mail address set forth on the signature pages attached hereto (or separately provided to the Company) at or prior to 5:30 p.m. (New York City time) on a Trading Day, (b) the next Trading Day
after the date of transmission, if such notice or communication is delivered via facsimile or e-mail at the facsimile number or e-mail address set forth on the signature pages attached hereto (or separately provided to the Company) on a day that is
not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given.
The address for such notices and communications shall be as set forth on the signature pages attached hereto. 
 5.5
Amendments; Waivers. No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an amendment, by the Company and the Purchasers holding at least 67% in interest of the
Securities then outstanding or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought. Notwithstanding the foregoing, any amendment, waiver, consent or approval by Purchasers holding at least 67% of
the Securities then outstanding shall be effective as to all Purchasers. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any
subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. 

5.6 Headings. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof. 
 5.7 Successors and Assigns. This Agreement shall be binding upon and
inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any
Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by
the provisions of the Transaction Documents that apply to the “Purchasers.” 

  
 32 

 5.8 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.10. 

5.9 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction
Documents shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal proceedings concerning the
interpretations, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners,
members, employees or agents) shall be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of
New York, Borough of Manhattan for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents),
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is improper or is an inconvenient
venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified mail or overnight delivery
(with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be
deemed to limit in any way any right to serve process in any other manner permitted by law. If either party shall commence an action, suit or proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of
the Company under Section 4.10, the prevailing party in such action, suit or proceeding shall be reimbursed by the other party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and
prosecution of such action or proceeding. 
 5.10 Survival. The representations and warranties contained herein shall
survive the Closing and the delivery of the Securities until no Debentures are outstanding. 
 5.11 Execution. This
Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it
being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. 

5.12 Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
to be invalid, illegal, void or unenforceable, the 

  
 33 

 
remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties
hereto shall use their commercially reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and
declared to be the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. 

5.13 Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained in (and without limiting any similar
provisions of) any of the other Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein
provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights;
provided, however, that in the case of a rescission of a conversion of a Debenture, the applicable Purchaser shall be required to return any shares of Common Stock subject to any such rescinded conversion. 

5.14 Replacement of Securities. If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or
destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of
evidence reasonably satisfactory to the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated
with the issuance of such replacement Securities. 
 5.15 Remedies. In addition to being entitled to exercise all rights
provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate
compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at
law would be adequate. 
 5.16 Payment Set Aside. To the extent that the Company makes a payment or payments to any
Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be
fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy
law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred. 

  
 34 

 5.17 Usury. To the extent it may lawfully do so, the Company hereby agrees not to
insist upon or plead or in any manner whatsoever claim, and will resist any and all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any claim, action
or proceeding that may be brought by any Purchaser in order to enforce any right or remedy under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document, it is expressly agreed and provided that
the total liability of the Company under the Transaction Documents for payments in the nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the
foregoing, in no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate.
It is agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract
rate of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in
excess of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Purchaser to the unpaid principal balance of any such indebtedness or be
refunded to the Company, the manner of handling such excess to be at such Purchaser’s election. 
 5.18 Independent
Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed
to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the
transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including, without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in its review and negotiation of the
Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do so by any of the Purchasers. 

5.19 Liquidated Damages. The Company’s obligations to pay any partial liquidated damages or other amounts owing under the
Transaction Documents is a continuing obligation of the Company and shall not terminate until all unpaid liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such liquidated
damages or other amounts are due and payable shall have been canceled. 

  
 35 

 5.20 Saturdays, Sundays, Holidays, etc. If the last or appointed day for the taking
of any action or the expiration of any right required or granted herein shall not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day. 

5.21 Construction. The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to
revise the Transaction Documents and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any
amendments thereto. In addition, each and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other
similar transactions of the Common Stock that occur after the date of this Agreement. 
 5.22 WAIVER OF JURY
TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY, UNCONDITIONALLY,
IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY. 
 (Signature Pages Follow) 

  
 36 

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be
duly executed by their respective authorized signatories as of the date first indicated above. 
  

									
	SCOLR PHARMA, INC. 	  		  	 Address for Notice:

19204 North Creek Parkway
 Suite 100

Bothell, Washington 98011

				
	 By:
	  	 /s/ Richard M. Levy
	  		  	Fax:
		  	Name:	  	Richard M. Levy	  		  	(425) 368-1051
		  	Title:	  	Executive Vice President and Chief Financial Officer	  		  	

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK 

SIGNATURE PAGE FOR PURCHASER FOLLOWS] 

  
 37 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Donald V. Moline

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ D. V. Moline

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 E-mail Address of Authorized Signatory: ######@#####.### 
 Facsimile Number of Authorized Signatory: (###) ###-#### 
 Address for Notice to Purchaser:

 ### ### ###### #### ## 
 ######, ##
##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 

Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 38 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Frank Gimenez & Philomena
Gimenez

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Frank Gimenez

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Philomena Gimenez

 

			
	Name of Authorized Signatory:	 	 Frank & Philomena Gimenez

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 N/A

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ##### #### ## 
 ############, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 39 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	  	 Woodrow W. Gunter, II

  

			
	Signature of Authorized Signatory of Purchaser:	  	 /s/ Woodrow W. Gunter

 

			
	Signature, if Joint Tenants or Tenants in Common:	  	  

 

			
	Name of Authorized Signatory:	  	  

 

			
	Title of Authorized Signatory:	  	  

 

			
	E-mail Address of Authorized Signatory:	  	 ########@########.##.###

 

			
	Facsimile Number of Authorized Signatory:	  	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### ###### ### 
 ##########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $6,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 40 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	 Name of Purchaser:
	 	 Douglas Friedrich & Melanie Friedrich
JT/WROS

  

			
	Signature of Authorized Signatory of Purchaser:	 	  

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Douglas Friedrich Melanie
Friedrich

  

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

					
	E-mail Address of Authorized Signatory:	 	 ########@###.###

  

					
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### #### #### ### 
 ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 41 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Justin Gasarch

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Justin Gasarch

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Justin Gasarch

 

			
	Title of Authorized Signatory:	 	 Owner

  

			
	E-mail Address of Authorized Signatory:	 	 N/A

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ##### ## 
 ######## ###, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 42 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Randall S. Knox

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Randall S. Knox

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 #####@######.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ######### ### 
 #### ########, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 43 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Dale M. Mayol

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Dale M. Mayol

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ######@#########.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ###### 
 ##########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 44 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Kenneth E. King

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Kenneth E. King

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 #########@#.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ######## ## 
 #####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 45 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Kenneth W. Cleveland

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Kenneth W. Cleveland

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 #######@#####.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ######### #### 
 ##########, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 46 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Andrew K. Light

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Andrew K. Light

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Andrew K. Light

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ######@##########.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ######### ###### 
 ############, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $20,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 47 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Andrew Hargroder

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Andrew Hargroder

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Andrew Hargroder

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ##########@###.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ######## ## 
 ##### #####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 48 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Arthur D. & Marie E.
Sterling

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Arthur D. Sterling

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Marie E. Sterling

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 #############@#####.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ###### ##### ###### ## 
 ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 49 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Angus Bruce Lauralee Bruce JT
WROS

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Angus Bruce

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Lauralee Bruce

 

			
	Name of Authorized Signatory:	 	 Angus Bruce

 

			
	Title of Authorized Signatory:	 	 Lauralee Bruce

  

			
	E-mail Address of Authorized Signatory:	 	 ###########@#####.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ######### ## 
 ### ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 50 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 John R. Bertsch Trust

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ John R. Bertsch

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ########@###.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ##### #### #### ## 
 ##### ######, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 51 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 David G. Linville

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ David G. Linville

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 #####@##################.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ######## ## 
 #### ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 52 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 David R. Gienapp

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ David R. Gienapp

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 David R. Gienapp

 

			
	Title of Authorized Signatory:	 	 Individual

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $3,200
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 53 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Mark Ravich

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Mark Ravich

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ######@###.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###)###-####

 Address for Notice to Purchaser: 
 ###### ######## ## 
 ##########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 54 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 John Junge

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ John P. Junge, Trustee

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ###@#######.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### #### 
 #### ##### ##, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $200,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 55 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Michael D. Dunham

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Michael D. Dunham

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	 Name of Authorized Signatory:
	 	  

 

			
	 Title of Authorized Signatory:
	 	  

 

					
		  	E-mail Address of Authorized Signatory:	 	   ###########@###########.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### # ### ## 
 ##########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 56 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	 Name of Purchaser:
	 	 Bibicoff Family Trust

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Harvey Bibicoff

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	 Name of Authorized Signatory:
	 	 Harvey Bibicoff

  

			
	 Title of Authorized Signatory:
	 	 Trustee

  

			
	 E-mail Address of Authorized Signatory:
	 	 ######@#######.###

  

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ####### #### 
 ### ### 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for
notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $30,000
	  	

  

					
	 EIN Number:
	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 57 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Shadow Capital LLC

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ B. Kent Garlinghouse

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 B. Kent Garlinghouse

 

			
	Title of Authorized Signatory:	 	 Manager

  

			
	E-mail Address of Authorized Signatory:	 	 #############@#####.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

Address for Notice to Purchaser: 
 #### ## ####
## 
 ######, ## ##### 
 Address for
Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $40,000
	  	

  

					
	EIN Number:	 	 ##-#######
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 58 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Nationwide Fleet Services
Inc.

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Hubert Kirt Fouque

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Hubert Kirt Fouque

 

			
	Title of Authorized Signatory:	 	 President

  

			
	 E-mail Address of Authorized Signatory:
	 	 #####@###############.###

  

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### # ####### #### 
 ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $34,000
	  	

  

					
	EIN Number:	 	 ##-#######
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 59 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Dennis Fortin

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Dennis Fortin

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	 E-mail Address of Authorized Signatory:
	 	 #######@#############.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

Address for Notice to Purchaser: 
 ## #########
## 
 ######, ## ##### 
 Address for
Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $30,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 60 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Steven A. Boggs

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Steven A. Boggs

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Steven A. Boggs

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ############@####.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ##### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 61 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Mark S. Bourque

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ same

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 N/A

 

			
	Name of Authorized Signatory:	 	 same

 

			
	Title of Authorized Signatory:	 	 owner

 

			
	E-mail Address of Authorized Signatory:	 	
########@#################.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #/# ##########-######## 
 #### #### ### ### 

#######, ## ##### 
 Address for Delivery of
Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 62 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Ray W. Cruz

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Ray W. Cruz

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 #############@#####.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ######## ## 
 #########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 63 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 David Stetson

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ David Stetson

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	 Name of Authorized Signatory:
	 	 David Stetson

 

			
	 Title of Authorized Signatory:
	 	  

 

			
	 E-mail Address of Authorized Signatory:
	 	 #####@##########.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ###### ####### ## 
 ###### ######, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $30,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 64 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Tad Wilson

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Tad Wilson

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ##### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 65 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	 Name of Purchaser:
	 	 John W. Crow

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ John W. Crow

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	 Name of Authorized Signatory:
	 	  

 

			
	 Title of Authorized Signatory:
	 	  

 

			
	 E-mail Address of Authorized Signatory:
	 	 #####@###.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ##### #### ## 
 ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $7,500
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 66 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	 Name of Purchaser:
	 	 John Tschohl

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ John Tschohl

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	 Name of Authorized Signatory:
	 	  

 

			
	 Title of Authorized Signatory:
	 	  

 

			
	 E-mail Address of Authorized Signatory:
	 	 #########@###.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### #### #### ###### 
 ############, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 67 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Albert Esposito & Margeret Esposito
JTWROS

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Albert Esposito

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Margeret Esposito

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ########## ## 
 ###########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 68 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Charles B. Hilton

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Charles B. Hilton

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ##########@#########.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ######### ## 
 ### ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $20,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 69 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Glenn R. Hubbard

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Glenn R. Hubbard

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### # ######### ####### ## 
 ########, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $12,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 70 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 David Frank Rios & Margaret Jo Rios 1999 Trust
Dtd.

  

			
	Signature of Authorized Signatory of Purchaser:	  	 /s/ David Rios

 

			
	Signature, if Joint Tenants or Tenants in Common:	  	 /s/ David Rios, TTEE

 

			
	Name of Authorized Signatory:	  	 /s/ Margaret Rios

 

			
	Title of Authorized Signatory:	  	 Margaret Rios – TTEE

 

			
	E-mail Address of Authorized Signatory:	  	 N/A

 

			
	Facsimile Number of Authorized Signatory:	  	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### #### ####### #### 
 #######, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $6,000
	  	

  

					
	 EIN Number:
	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 71 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Richard Buchakjian

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Richard Buchakjian

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	Name of Authorized Signatory:	 	  

  

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	  	 N/A

  

			
	Facsimile Number of Authorized Signatory:	  	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ###### ### 
 ##### ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $4,000
	 	

  

					
	EIN Number:	 	 ###-##-####
	 	

 [SIGNATURE PAGES CONTINUE] 

  
 72 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Mark & Debra Ladendorf

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Mark C. Ladendorf    Debra
Ladendorf

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Debra Ladendorf    Mark C.
Ladendorf

  

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ####@#########.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ####### ### 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	 Subscription Amount:
	 	 $10,000
	  	

  

					
	 EIN Number:
	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 73 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Wulf Paulick & Renate Paulick
JT/WROS

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Wulf Paulick

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Renate Paulick

 

			
	Name of Authorized Signatory:	 	 Wulf Paulick & Renate
Paulick

  

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ###########@###.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ########### ### # 
 ##### ####### 
 ####### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice):

 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 74 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Robert H. Mapp

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Robert H. Mapp

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	Name of Authorized Signatory:	 	  

  

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### ### 
 ############, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $2,400
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 75 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Paul Seid

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Paul Seid

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ####.####@#####.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ######### ## 
 ### ####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $50,000
	 	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 76 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Peter K. Nitz

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Peter K. Nitz

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ########@#####.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ##### ## 
 ######## ###, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $15,000
	 	

  

					
	EIN Number:	 	 ###-##-####
	 	

 [SIGNATURE PAGES CONTINUE] 

  
 77 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 George Bonomo

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ George Bonomo

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 George Bonomo

 

			
	Title of Authorized Signatory:	 	 Owner

 

			
	E-mail Address of Authorized Signatory:	 	 #######@###.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 # ## ### ##### ## 
 ##########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $3,000
	 	

  

					
	EIN Number:	 	 ###-##-####
	 	

 [SIGNATURE PAGES CONTINUE] 

  
 78 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Peter C. Murphy

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Peter C. Murphy

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ### ####### ## 
 ## ######, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 79 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 The Starr F. Scholobohm Rev. Trust Dtd.
12/09/2004

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Starr F. Scholobohm

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Starr F. Scholobohm

 

			
	Title of Authorized Signatory:	 	 Trustee

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ######### ## 
 #########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 80 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Samuel E. Leonard Trust

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Samuel E. Leonard TTEE

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	 E-mail Address of Authorized Signatory:
	 	 #######@#######.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

Address for Notice to Purchaser: 
 #### ###
##### 
 ##########, ## ##### 
 Address
for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $2,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 81 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Merle F. Stockley Jr.

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Merle F. Stockley Jr.

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	 E-mail Address of Authorized Signatory:
	 	 ###########@####.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

Address for Notice to Purchaser: 
 ## ### #####

 #########, ## ##### 
 Address for
Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 82 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Raymond M. Beebe & Joan P. Beebe JT TEN

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Raymond M. Beebe

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Joan P. Beebe

  

			
	Name of Authorized Signatory:	 	 Raymond M. Beebe & Joan P. Beebe

  

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ######@############.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### #### ### 
 ###### ####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $17,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 83 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 D& M Partners

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Dean Weinberg

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Dean Weinberg

 

			
	Title of Authorized Signatory:	 	 Partner

 

			
	E-mail Address of Authorized Signatory:	 	 ############@#####.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### # ####### ### 
 ########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 84 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Robert P. Giesen

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Robert P. Giesen

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 #######@#########.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ########## ## 
 #### #####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $3,500
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 85 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Robert G. Welty

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Robert G. Welty

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 #######@###.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ####### ######## ##### 
 ##########, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $3,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 86 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Carla A Quimby Trust UAD 12/30/94 Carl A Quimby
TTEE

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Carla A Quimby TTEE

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Carla A Quimby TTEE

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 N/A

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ######## ## 
 #########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 87 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Frank M. Elliott

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Frank M. Elliott

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 N/A

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ##### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,600
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 88 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Michael Foster & Kathryn L. Foster JTWROS TOD Dtd.
1/6/04

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Michael Foster

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Kathryn Foster

 

			
	Name of Authorized Signatory:	 	 Michael Foster

 

			
	Title of Authorized Signatory:	 	 Kathryn Foster

 

			
	E-mail Address of Authorized Signatory:	 	 ##########.#######@#####.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 # #### ###### ## 
 ### ######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 89 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 E. H. Arnold

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ E. H. Arnold

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ###@#########.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #/# ###### ######### 
 ### ##### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for
notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 90 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Robert F. Taglich

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Robert F. Taglich

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 N/A

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 # ##### ##### ## 
 #### ###### ######, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $25,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 91 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Michael Taglich

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Michael Taglich

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ########@###############.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ### #### ### 
 ### ### 
 ##########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for
notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $50,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 92 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 W. Lewis Duvall

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ W. Lewis Duvall

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	 E-mail Address of Authorized Signatory:
	 	 N/A

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

Address for Notice to Purchaser: 
 ## ### ##

 #########, ## ##### 
 Address for
Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 93 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Norper Investments Inc.

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Norman Perry

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Norman Perry

 

			
	Title of Authorized Signatory:	 	 President

  

			
	 E-mail Address of Authorized Signatory:
	 	 ######@###.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

Address for Notice to Purchaser: 
 ##
########## ## 
 ####### 
 ###### ######

 ###### 
 Address for Delivery of
Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ##-#######
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 94 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Michael P. Hagerty

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Michael P. Hagerty

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Michael P. Hagerty

 

			
	Title of Authorized Signatory:	 	  

  

			
	 E-mail Address of Authorized Signatory:
	 	 #######@###.###

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

Address for Notice to Purchaser: 
 #### ####
###### ## 
 #######, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 95 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Michael D. Stedem

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Michael D. Stedem

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 N/A

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ###### ####### ## 
 ########, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $3,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 96 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Walter Parkes

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Walter Parkes

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 N/A

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 # ######### ### 
 #########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $6,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 97 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Sandra P. Nitz

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Sandra P. Nitz

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ########@#####.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ##### ## 
 ######## ###, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 98 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Lawrence D. Feldhacker

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Lawrence D. Feldhacker

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 #######@###.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ##### ######## ## 
 #####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 99 

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Stephen Hughes

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Stephen Hughes

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ########@#####.####

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #/# ###### ###### & ###### 
 ## ### ## 

########, ## ##### 
 Address for Delivery of
Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 100

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Three Treasures LP

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ W K Neely

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	Name of Authorized Signatory:	 	 W K Neely

  

			
	Title of Authorized Signatory:	 	 President

  

			
	E-mail Address of Authorized Signatory:	 	 #####@###############.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ###### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ##-#######
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 101

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Dr. Mordecai Bluth

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Dr. Mordecai Bluth

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	Name of Authorized Signatory:	 	  

  

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ######@###.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### #### ## 
 ########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 102

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Roy Smith & Joyce L. Smith
JTWROS

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Roy Smith

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Joyce L. Smith

 

			
	Name of Authorized Signatory:	 	 Roy Smith

 

			
	Title of Authorized Signatory:	 	 Owners

 

			
	E-mail Address of Authorized Signatory:	 	 ###@###########.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ##### ###### ## 
 ##### #######, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 103

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Robert C. Koski

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Robert C. Koski

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Robert C. Koski

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ############@#######.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## #### ########### ## 
 ########, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $24,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 104

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Peter Fitzpatrick

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Peter Fitzpatrick

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	 Name of Authorized Signatory:
	 	  

 

			
	 Title of Authorized Signatory:
	 	  

 

			
	 E-mail Address of Authorized Signatory:  
	 	 N/A

 

			
	 Facsimile Number of Authorized Signatory:
	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ###### ## 
 #########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 105

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 C. Mark Casey

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ C. Mark Casey

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	 Name of Authorized Signatory:
	 	 C. Mark Casey

  

			
	 Title of Authorized Signatory:
	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ##########@#######.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #/# ###### ###### ##### ##### 
 ### # ########## ## ### ## 

########## ######, ## ##### 
 Address for
Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 

 

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	 EIN Number:
	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 106

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Bennett Greenspon

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Bennett Greenspon

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ######@#########.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

Address for Notice to Purchaser: 
 ##### #
######### ## 
 #####, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	 Subscription Amount:
	 	 $5,000
	  	

  

					
	 EIN Number:
	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 107

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Gary L. Manka

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Gary L. Manka

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	Name of Authorized Signatory:	 	  

  

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ######@#########.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ##### ### ## 
 ### #### 
 ###########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address
for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	 EIN Number:
	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 108

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Larry V. Lowrance

 

			
	Signature of Authorized Signatory of Purchaser:	  	 /s/ Larry V. Lowrance

 

			
	Signature, if Joint Tenants or Tenants in Common:	  	  

 

			
	Name of Authorized Signatory:	  	  

 

			
	Title of Authorized Signatory:	  	  

 

			
	E -mail Address of Authorized Signatory:	  	 #########@#######.###

 

			
	Facsimile Number of Authorized Signatory:	  	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ####### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 109

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	 Name of Purchaser:
	  	 Tom Hirsch & Maureen A.
Hirsch

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Tom Hirsch

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Maureen A. Hirsch

 

			
	 Name of Authorized Signatory:
	  	 Maureen A. Hirsch

 

			
	 Title of Authorized Signatory:
	  	  

 

			
	 E-mail Address of Authorized Signatory:
	  	 #######@########.###

 

			
	 Facsimile Number of Authorized Signatory:
	  	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### #### 
 #####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 110

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	  	 Scot Holding Inc.

 

			
	Signature of Authorized Signatory of Purchaser:	  	 /s/ Patrick Gordon

 

			
	Signature, if Joint Tenants or Tenants in Common:	  	  

 

			
	Name of Authorized Signatory:	 	 Patrick Gordon

 

			
	Title of Authorized Signatory:	 	 President

 

			
	E-mail Address of Authorized Signatory:	  	 #######@#########.###

 

			
	Facsimile Number of Authorized Signatory:	  	 (###) ###-####

 Address for Notice to Purchaser: 
 ### #### #### ### ### 
 ## ####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $10,000
	  	

  

					
	EIN Number:	 	 ##-#######
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 111

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	  	 Phillip L. Burnett & Allyson Burnett, Husband and
Wife

  

			
	Signature of Authorized Signatory of Purchaser:	  	 /s/ Phillip L. Burnett

 

			
	Signature, if Joint Tenants or Tenants in Common:	  	 /s/ Allyson Burnett

 

			
	Name of Authorized Signatory:	  	  

 

			
	Title of Authorized Signatory:	  	  

 

			
	E-mail Address of Authorized Signatory:	  	 ###########@##########.###

 

			
	Facsimile Number of Authorized Signatory:	  	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ### ###### ## 
 ## ##### ####, ## ##### 

Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 112

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Ronald A. Rayson

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Ronald A. Rayson

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 N/A

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### #### 
 #########, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 113

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Bruce Newell

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Bruce Newell

  

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

  

			
	Name of Authorized Signatory:	 	  

  

			
	Title of Authorized Signatory:	 	  

  

			
	E-mail Address of Authorized Signatory:	 	 ####@#######.###

  

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ### ########## 
 ## ##### ####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	 	

  

					
	EIN Number:	 	 ###-##-####
	 	

 [SIGNATURE PAGES CONTINUE] 

  
 114

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Gary L. Gray

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Gary L. Gray

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 #####@########.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### ## 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	 	

 [SIGNATURE PAGES CONTINUE] 

  
 115

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Scott J. Isaak

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Scott J. Isaak

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	  

 

			
	Title of Authorized Signatory:	 	  

 

			
	E-mail Address of Authorized Signatory:	 	 ######@##.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ## ### ### 
 ###### ####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $5,000
	  	

  

					
	EIN Number:	 	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 116

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Zanett Opportunity Fund, Ltd.

 

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Zachary McAdoo

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Zachary McAdoo

 

			
	Title of Authorized Signatory:	 	 President, McAdoo Capital, Investment
Manager

  

			
	E-mail Address of Authorized Signatory:	 	 #######@#############.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 ###### ##### 
 ## ######## ## 
 ######## ## ## 
 ####### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	 	 $50,000
	  	

  

					
	EIN Number:	 	 ##-#######
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 117

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 Thomas J. Bean / Big Red
Investment

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ Thomas J. Bean

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	  

 

			
	Name of Authorized Signatory:	 	 Thomas J. Bean

 

			
	Title of Authorized Signatory:	 	 Manager of General Partner

 

			
	E-mail Address of Authorized Signatory:	 	 ###@#######.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### # ##### ## 
 ### ### 
 #####, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for
notice): 
 Same as above. 
  

					
	Subscription Amount:	  	 $15,000
	  	

  

					
	EIN Number:	  	 ##-#######
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 118

 [PURCHASER SIGNATURE PAGES TO SCLR SECURITIES PURCHASE AGREEMENT] 

IN WITNESS WHEREOF, the undersigned have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above. 
  

			
	Name of Purchaser:	 	 William M. Stokes or Rebecca A. Stokes
JTWROS

  

			
	Signature of Authorized Signatory of Purchaser:	 	 /s/ William M. Stokes

 

			
	Signature, if Joint Tenants or Tenants in Common:	 	 /s/ Rebecca A. Stokes

 

			
	Name of Authorized Signatory:	  	  

 

			
	Title of Authorized Signatory:	 	 N/A

 

			
	E-mail Address of Authorized Signatory:	 	 #######@####.###

 

			
	Facsimile Number of Authorized Signatory:	 	 (###) ###-####

 Address for Notice to Purchaser: 
 #### ####### #### 
 #######, ## ##### 
 Address for Delivery of Securities to Purchaser (if not same as address for notice): 
 Same as
above. 
  

					
	Subscription Amount:	  	 $5,000
	  	

  

					
	EIN Number:	  	 ###-##-####
	  	

 [SIGNATURE PAGES CONTINUE] 

  
 119

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]